Yield10 Bioscience, Inc. (YTEN) Reports Q2 Loss of $0.24

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ACCV
4. LLY
5. FLG
6. META
7. FICO
8. GMAB
9. QQQ
10. TSLA

Go back to Yield10 Bioscience, Inc. (YTEN) Reports Q2 Loss of $0.24

Yield10 Bioscience, Inc. (YTEN) Signs Research License Agreement Covering CRISPR-Cas9 Genome-Editing Technology

August 8, 2018 8:42 AM EDT

Yield10 Bioscience, Inc. (Nasdaq: YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today announced it has signed a non-exclusive research license agreement jointly with the Broad Institute of MIT and Harvard and Pioneer, part of Corteva AgriscienceTM Agriculture Division of DowDuPont (NYSE: DWDP), for the use of CRISPR-Cas9 genome-editing technology for crops. The joint license covers intellectual property consisting of approximately 48 patents and patent applications on CRISPR-Cas9 technology controlled by the Broad Institute and Pioneer.... More